Palvella Therapeutics, Inc. ( PVLA) - Key Metrics
PVLA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.52 | -$0.89 | -$0.89 |
| 2026Q1 | $0 | -$1.20 | -$0.83 | -$0.83 |
| 2025Q4 | $0 | -$1.13 | -$0.44 | -$0.44 |
| 2025Q3 | $0 | -$1.03 | -$0.71 | -$0.71 |
| 2025Q2 | $0 | -$0.86 | -$0.49 | -$0.49 |
PVLA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -25.13 |
| 2026Q1 | 0% | -25.97 |
| 2025Q4 | 0% | -24.23 |
| 2025Q3 | 0% | -15.22 |
| 2025Q2 | 0% | -6.55 |
PVLA
Price: $140.99
52 week price:
Earnings Per Share: -4.69 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.2 billion